Ex-FDA chief Scott Gottlieb joins big pharma

Ever since Dr Scott Gottlieb unexpectedly stepped down as head of the US Food and Drug Administration in March this year, less than two years into his tenure, there has been speculation about where he would re-appear. Now we have the answer – US pharma giant Pfizer (NYSE: PFE).

The former FDA Commissioner has been named to the Pfizer board of directors, with immediate effect, and has also been appointed to the Regulatory and Compliance Committee and the Science and Technology Committee of Pfizer’s board.

During his time Commissioner, Dr Gottlieb he was instrumental in new legislation and guidance to push the faster approval of generics and biosimilars, as well as seriously vociferous in the fight against unwarranted drug price hikes and the high cost of medicines for American consumers.